Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024

Rhea-AI Summary

Terns Pharmaceuticals, a clinical-stage biopharmaceutical company, will participate in The Citizens JMP Life Sciences Conference 2024. Senior management will join a fireside chat to discuss the company's small-molecule product candidates for serious diseases like oncology and obesity. The event will be live webcasted on May 14, 2024, at 1:30 p.m. ET, with a replay available for 30 days.

FOSTER CITY, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced that members of senior management will be participating in a fireside chat at The Citizens JMP Life Sciences Conference 2024 on Tuesday, May 14, 2024 at 1:30 p.m. ET.

A live webcast of the fireside chat will be available on the investor relations page of the Terns Pharmaceuticals website at http://ir.ternspharma.com. A replay of the webcast will be archived on Terns’ website for 30 days following the event.

About Terns Pharmaceuticals
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline includes three clinical-stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-β agonist, and a preclinical GIPR modulator program. For more information, please visit: www.ternspharma.com.

Contacts for Terns

Investors
Justin Ng
investors@ternspharma.com 

Media
Jenna Urban
Berry & Company Public Relations
media@ternspharma.com 

 

FAQ

When will Terns Pharmaceuticals participate in The Citizens JMP Life Sciences Conference 2024?

Terns Pharmaceuticals will participate in The Citizens JMP Life Sciences Conference 2024 on Tuesday, May 14, 2024, at 1:30 p.m. ET.

What type of company is Terns Pharmaceuticals?

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company.

What diseases does Terns Pharmaceuticals focus on?

Terns Pharmaceuticals focuses on serious diseases like oncology and obesity.

Where can I watch the webcast of the fireside chat?

The webcast of the fireside chat will be available on the investor relations page of the Terns Pharmaceuticals website.

How long will the webcast replay be available?

The webcast replay will be archived on Terns' website for 30 days following the event.